KR880005125A - 7-((m-치환된)페닐글리신)1-카바-1-데티아세팔로스포린 - Google Patents
7-((m-치환된)페닐글리신)1-카바-1-데티아세팔로스포린 Download PDFInfo
- Publication number
- KR880005125A KR880005125A KR870011038A KR870011038A KR880005125A KR 880005125 A KR880005125 A KR 880005125A KR 870011038 A KR870011038 A KR 870011038A KR 870011038 A KR870011038 A KR 870011038A KR 880005125 A KR880005125 A KR 880005125A
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- hydrogen
- pharmaceutically
- carba
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (8)
- 하기 일반식(I)의 화합물 또는 그의 약제학적으로 무독한 염.상기식에서 R1은 C1내지 C4의 알킬이다.
- 제1항에 있어서, R1이 메틸 또는 에틸인 일반식(I)의 화합물 또는 그의 약제학적으로 무독한 염.
- 7β-[2'-(R)-2'-(m-(메틸설폰아미도)페닐)-2'-아미노아세트아미도]-3-클로로-3-(1-카바-1-데티아세펨)-4-카복실산.
- 7β-[2'-(R)-2'-(m-(에틸설폰아미도)페닐)-2'-아미노아세트아미도]-3-클로로-3-(1-카바-1-데티아세펨)-4-카복실 산.
- 제1항 내지 4항중 어느 한 항에서 청구된 화합물 또는 그의 약제학적으로 무독한 염 및 약제학적으로 무독한 담체로 이루어짐을 특징으로 하는 약제학적 조성물.
- 제1항 내지 4항중 어느 한 항에서 청구된 일반식 (I)의 화합물 또는 그의 약제학적으로 무독한 염을세균성 전염병에 걸려 있거나 걸리기 쉬운 온혈동물에 투여함을 특징으로 하여 온혈동물의 세균성 전염병을치료하는 방법.
- (A) 하기 일반식(II)화합물의 아미노 및/또는 카복시 보호 그룹을 제거하거나, (B) 일반식(III)의 화합물을 아실화시키고 Q2가 수소가 아닌 경우 존재하는 아미노 보호 그룹 및 카복시 보호 그룹을 제거하거나, (C) Q 및 Q2가 각각 수소인(II)화합물의 라세미 혼합물을 단리시킴을 특징으로 하여 제1항 내지 4항중 어느 한 항에서 청구된 일반식(I)의 화합물 또는 그의 약제학적으로 무독한 염을 제조하는 방법.상기식에서 Q 또는 수소, 또는 아미노 보호 그룹이고 Q2는 수소 또는 카복시 보호 그룹인데 단, Q 및 Q2가 동시에 수소이어서는 안된다.
- Q 및 Q2가 동시에 수소일 수는 없는 제7항에서 정의된 일반식(II)의 화합물.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91517386A | 1986-10-03 | 1986-10-03 | |
US06/915173 | 1986-10-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR880005125A true KR880005125A (ko) | 1988-06-28 |
Family
ID=25435354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR870011038A KR880005125A (ko) | 1986-10-03 | 1987-10-02 | 7-((m-치환된)페닐글리신)1-카바-1-데티아세팔로스포린 |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0266896B1 (ko) |
JP (1) | JPS6396186A (ko) |
KR (1) | KR880005125A (ko) |
CN (1) | CN87107149A (ko) |
AT (2) | ATE79119T1 (ko) |
BG (1) | BG47034A3 (ko) |
DE (1) | DE3780909T2 (ko) |
DK (1) | DK518487A (ko) |
FI (1) | FI874311A (ko) |
GR (1) | GR3005920T3 (ko) |
HU (1) | HU200179B (ko) |
IE (1) | IE872646L (ko) |
IL (1) | IL84051A0 (ko) |
NZ (1) | NZ222015A (ko) |
PL (1) | PL151703B1 (ko) |
PT (1) | PT85850B (ko) |
ZA (1) | ZA877398B (ko) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1750429A3 (ru) * | 1988-02-05 | 1992-07-23 | Эли Лилли Энд Компани (Фирма) | Способ получени кристаллического 2,5-гидрата-1-карбацефалоспорина |
WO2002079174A2 (en) | 2001-03-28 | 2002-10-10 | Schering Corporation | Enantioselective synthesis of azetidinone intermediate compounds |
US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
AU2003298513A1 (en) * | 2002-05-14 | 2004-05-13 | Northwestern University | STERICALLY-AWKWARD Beta-LACTAMASE INHIBITORS |
WO2004081002A1 (en) | 2003-03-07 | 2004-09-23 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
US7208486B2 (en) | 2003-03-07 | 2007-04-24 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
CN102144992B (zh) * | 2011-03-10 | 2013-04-10 | 浙江大学 | 苯基甘氨酸衍生物制备对金黄色葡萄球菌有抑菌和杀菌活性的抗菌剂的用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3697515A (en) * | 1963-02-18 | 1972-10-10 | Ciba Geigy Corp | Process for splitting the 7-n-acyl group from cephalosporin compounds |
JPS5672698A (en) * | 1979-11-14 | 1981-06-16 | Kyowa Hakko Kogyo Co Ltd | Preparation of optically active cephalosporin analogue |
NO155548C (no) * | 1979-02-10 | 1987-04-15 | Kyowa Hakko Kogyo Kk | Fremgangsmaate til fremstilling av optisk aktive cefalosporin-analoger. |
NO155547C (no) * | 1979-02-10 | 1987-04-15 | Kyowa Hakko Kogyo Kk | Optisk aktive cefalosporin-analoge og salter derav samt fremgangsmaate for deres fremstilling. |
JPS60174787A (ja) * | 1984-02-21 | 1985-09-09 | Kyowa Hakko Kogyo Co Ltd | 3位置換カルバセフエム化合物 |
US4673737A (en) * | 1985-08-02 | 1987-06-16 | Harvard University | 7-acylamino-(or 7-amino)-3-trifluoromethylsulfonyloxy-1-carba(1-dethia)-3-cephem-4-carboxylic acids and esters thereof |
-
1987
- 1987-10-01 EP EP87308713A patent/EP0266896B1/en not_active Expired - Lifetime
- 1987-10-01 ZA ZA877398A patent/ZA877398B/xx unknown
- 1987-10-01 FI FI874311A patent/FI874311A/fi not_active IP Right Cessation
- 1987-10-01 DE DE8787308713T patent/DE3780909T2/de not_active Expired - Fee Related
- 1987-10-01 PT PT85850A patent/PT85850B/pt unknown
- 1987-10-01 NZ NZ222015A patent/NZ222015A/xx unknown
- 1987-10-01 CN CN198787107149A patent/CN87107149A/zh active Pending
- 1987-10-01 AT AT87308713T patent/ATE79119T1/de not_active IP Right Cessation
- 1987-10-01 IL IL84051A patent/IL84051A0/xx unknown
- 1987-10-02 PL PL1987268034A patent/PL151703B1/pl unknown
- 1987-10-02 DK DK518487A patent/DK518487A/da not_active Application Discontinuation
- 1987-10-02 KR KR870011038A patent/KR880005125A/ko not_active Application Discontinuation
- 1987-10-02 IE IE872646A patent/IE872646L/xx unknown
- 1987-10-02 JP JP62250552A patent/JPS6396186A/ja active Pending
- 1987-10-02 BG BG81345A patent/BG47034A3/xx unknown
- 1987-10-02 HU HU874452A patent/HU200179B/hu not_active IP Right Cessation
- 1987-10-08 AT AT0257587A patent/AT388377B/de active
-
1992
- 1992-10-08 GR GR920402240T patent/GR3005920T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ATA257587A (de) | 1988-11-15 |
AU7926987A (en) | 1988-04-14 |
AT388377B (de) | 1989-06-12 |
GR3005920T3 (ko) | 1993-06-07 |
EP0266896A1 (en) | 1988-05-11 |
IE872646L (en) | 1988-04-03 |
NZ222015A (en) | 1989-10-27 |
PT85850A (en) | 1987-11-01 |
JPS6396186A (ja) | 1988-04-27 |
HUT45053A (en) | 1988-05-30 |
BG47034A3 (en) | 1990-04-16 |
ATE79119T1 (de) | 1992-08-15 |
EP0266896B1 (en) | 1992-08-05 |
PL151703B1 (en) | 1990-09-28 |
ZA877398B (en) | 1989-05-30 |
AU591811B2 (en) | 1989-12-14 |
PT85850B (en) | 1990-01-12 |
IL84051A0 (en) | 1988-03-31 |
FI874311A (fi) | 1988-04-04 |
PL268034A1 (en) | 1988-09-01 |
HU200179B (en) | 1990-04-28 |
CN87107149A (zh) | 1988-05-18 |
DK518487A (da) | 1988-04-04 |
FI874311A0 (fi) | 1987-10-01 |
DE3780909D1 (en) | 1992-09-10 |
DK518487D0 (da) | 1987-10-02 |
DE3780909T2 (de) | 1993-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE150462T1 (de) | Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung | |
DE69025104D1 (de) | Thiazolderivate, Verfahren zur Ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten | |
AR019365A1 (es) | Compuesto de 1-piperidin-3-fenil-butil-naftamida, proceso para prepararlo, composicion farmaceutica y uso para fabricar un medicamento util para eltratamiento de una enfermedad por antagonistas de taquicininas neuropeptidicas endogenas | |
AU591780B2 (en) | Benzo{b}thiophene- and benzo{b}furancarboxamide derivatives their preparation, and pharmaceutical compositions containing them | |
MX9300552A (es) | Derivados de etanolamina | |
ATE142641T1 (de) | Neue peptid-verbindungen und verfahren zur herstellung davon | |
DE58904143D1 (de) | Arylalkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel. | |
FI945975A0 (fi) | Haarautuneella aminoryhmällä substituoituja tiatsoleja, menetelmiä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia | |
PT82897B (pt) | Processo de preparacao de derivados de di-hidropiridazinona | |
EA200000431A3 (ru) | Новые замещенные димерные соединения, способ их получения и фармацевтические композиции, содержащие их | |
KR880005125A (ko) | 7-((m-치환된)페닐글리신)1-카바-1-데티아세팔로스포린 | |
FI955085A (fi) | Uudet diosmetiiniyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
KR880011112A (ko) | 벤즈아제핀 설폰아미드 화합물 | |
KR910011880A (ko) | 신규 화합물 | |
EA200100984A1 (ru) | Новые кристаллические формы макролидного антибиотика | |
RU95102479A (ru) | Аналоги 15-дезоксиспергуалина, способ их получения и фармкомпозиция на их основе | |
ATE46172T1 (de) | Verbindungen, diese enthaltende pharmazeutische zusammensetzungen und verfahren zur herstellung. | |
PT77017B (fr) | Procede de preparation de nouveaux derives des cephalosporines utilisables comme antibiotiques | |
KR910006292A (ko) | 방향족 산의 n-아자비시클로 [3.3.0] 옥탄 아미드 | |
ES8800938A1 (es) | Procedimiento para preparar derivados berbanicos biologicamente activos. | |
KR870001218A (ko) | 3-클로로-치환된 세팔로스포린의 제조방법 | |
ES2010225A6 (es) | Procedimiento de preparacion de nuevos derivados de piperazina diona-2,6. | |
KR970006283A (ko) | 신규 아민고리 화합물 | |
ATE29251T1 (de) | Aminopyridincarbonsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
KR900009658A (ko) | 아실화 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |